You take a pill for your blood pressure. How do you know it contains the right amount of active ingredient? And no toxic impurities? Ion chromatography is part of the answer. The ion chromatography market research study shows that the pharmaceutical industry is the fastest‑growing application, with a CAGR above 8%. Why? Because regulators (FDA, EMA) require ion analysis for drug counterions, residual solvents, and degradation products.

What's tested? Counterions (e.g., sodium in diclofenac sodium), organic acids (e.g., acetate in heparin), and even genotoxic impurities like azides. The ion chromatography market trends highlight that the fastest‑growing technique is ion‑pair chromatography, which separates both charged and neutral species.

But pharmaceutical labs face a challenge: method validation. IC methods must be robust, specific, and sensitive. That's why many outsource to contract labs.

The bottom line: next time you take a pill, thank the analytical chemists who ensured its purity. Ion chromatography is a small but vital part of the quality control chain.